PUBLICACIÓN
The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases
Alonso-Navarro, H., Jiménez-Jiménez, F.J., García-Agúndez, J.A.
2006 Medicina Clinica
CITAS
5
DOI
10.1157/13088772
EID
2-s2.0-33745739711
ISSN
0025-7753
BIBTEX
@article { agundez2006,title = {The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases | Papel del polimorfismo genético CYP2C19 en los efectos adversos a fármacos y en el riesgo para diversas enfermedades},journal = {Medicina Clinica},year = {2006},volume = {126},number = {18},pages = {697-706},author = {Alonso-Navarro, H. and Jiménez-Jiménez, F.J. and García-Agúndez, J.A.}}
AUTORES DE LA UEX